The Scotts Miracle-Gro Company : Good timing to anticipate a continuation of the trend
BUY
Repli_rebond
Target price hit
Entry price | Target | Stop-loss | Potential |
---|
US$151 |
US$177 |
US$139 |
+17.22% |
---|
The timing appears opportune to go long in shares of The Scotts Miracle-Gro Company as we anticipate another pick-up in the underlying trend.
Summary● In a short-term perspective, the company has interesting fundamentals.
Strengths● Considering the small differences between the analysts' various estimates, the group's business visibility is good.
● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
● Over the past year, analysts have regularly revised upwards their sales forecast for the company.
● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
● Within the weekly time frame the stock shows a bullish technical configuration above the support level at 117.78 USD
Weaknesses● The stock is close to a major daily resistance at USD 162.52, which should be gotten rid of so as to gain new appreciation potential.
● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.